Bridgewater Associates’s NeoGenomics NEO Stock Holding History

Bridgewater Associates’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-91,190	Closed	-$677K	–	1119
2026 Q1	$677K	Buy	+91,190	New	+$960K	﹤0.01%	849
2025 Q1	–	Sell	-14,397	Closed	-$237K	–	756
2024 Q4	$237K	Sell	14,397 -35,957	-71%	-$558K	﹤0.01%	661
2024 Q3	$743K	Sell	50,354 -12,374	-20%	-$194K	﹤0.01%	639
2024 Q2	$870K	Buy	62,728 +38,121	+155%	+$540K	﹤0.01%	687
2024 Q1	$387K	Sell	24,607 -5,226	-18%	-$80.7K	﹤0.01%	643
2023 Q4	$483K	Sell	29,833 -118,513	-80%	-$1.94M	﹤0.01%	707
2023 Q3	$1.82M	Buy	148,346 +21,755	+17%	+$324K	0.01%	509
2023 Q2	$2.03M	Sell	126,591 -6,836	-5%	-$113K	0.01%	456
2023 Q1	$2.32M	Buy	+133,427	New	+$1.9M	0.01%	435

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Bridgewater Associates's NEO Position: Q2 2026 in Review

Bridgewater Associates sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 91,190 shares — an estimated $677K sold.

Bridgewater Associates first reported a position in NEO in Q1 2023 and held it in 9 quarters. The position peaked at $2.32M in Q1 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Bridgewater Associates reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
Bridgewater Associates sold 91,190 NeoGenomics shares in Q2 2026, an estimated $677K.
Bridgewater Associates first reported a position in NeoGenomics in Q1 2023 and held it in 9 quarters.
Bridgewater Associates's NeoGenomics position peaked at $2.32M in Q1 2023.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.